Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Oral Proteins and Peptides Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Linaclotide
      • 1.3.3 Plecanatide
      • 1.3.4 Calcitonin
      • 1.3.5 Insulin
      • 1.3.6 Octreotide
    • 1.4 Market Segment by Application
      • 1.4.1 Global Oral Proteins and Peptides Market Share by Application (2019-2025)
      • 1.4.2 Gastric & Digestive Disorders
      • 1.4.3 Bone Diseases
      • 1.4.4 Diabetes
      • 1.4.5 Hormonal Disorders
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Oral Proteins and Peptides Market Size
      • 2.1.1 Global Oral Proteins and Peptides Revenue 2014-2025
      • 2.1.2 Global Oral Proteins and Peptides Sales 2014-2025
    • 2.2 Oral Proteins and Peptides Growth Rate by Regions
      • 2.2.1 Global Oral Proteins and Peptides Sales by Regions 2014-2019
      • 2.2.2 Global Oral Proteins and Peptides Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Oral Proteins and Peptides Sales by Manufacturers
      • 3.1.1 Oral Proteins and Peptides Sales by Manufacturers 2014-2019
      • 3.1.2 Oral Proteins and Peptides Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Oral Proteins and Peptides Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Proteins and Peptides Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Oral Proteins and Peptides Market Concentration Ratio (CR5 and HHI)
    • 3.3 Oral Proteins and Peptides Price by Manufacturers
    • 3.4 Key Manufacturers Oral Proteins and Peptides Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Oral Proteins and Peptides Market
    • 3.6 Key Manufacturers Oral Proteins and Peptides Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Linaclotide Sales and Revenue (2014-2019)
      • 4.1.2 Plecanatide Sales and Revenue (2014-2019)
      • 4.1.3 Calcitonin Sales and Revenue (2014-2019)
      • 4.1.4 Insulin Sales and Revenue (2014-2019)
      • 4.1.5 Octreotide Sales and Revenue (2014-2019)
    • 4.2 Global Oral Proteins and Peptides Sales Market Share by Type
    • 4.3 Global Oral Proteins and Peptides Revenue Market Share by Type
    • 4.4 Oral Proteins and Peptides Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Oral Proteins and Peptides Sales by Application

    6 United States

    • 6.1 United States Oral Proteins and Peptides Breakdown Data by Company
    • 6.2 United States Oral Proteins and Peptides Breakdown Data by Type
    • 6.3 United States Oral Proteins and Peptides Breakdown Data by Application

    7 European Union

    • 7.1 European Union Oral Proteins and Peptides Breakdown Data by Company
    • 7.2 European Union Oral Proteins and Peptides Breakdown Data by Type
    • 7.3 European Union Oral Proteins and Peptides Breakdown Data by Application

    8 China

    • 8.1 China Oral Proteins and Peptides Breakdown Data by Company
    • 8.2 China Oral Proteins and Peptides Breakdown Data by Type
    • 8.3 China Oral Proteins and Peptides Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Oral Proteins and Peptides Breakdown Data by Company
    • 9.2 Rest of World Oral Proteins and Peptides Breakdown Data by Type
    • 9.3 Rest of World Oral Proteins and Peptides Breakdown Data by Application
    • 9.4 Rest of World Oral Proteins and Peptides Breakdown Data by Countries
      • 9.4.1 Rest of World Oral Proteins and Peptides Sales by Countries
      • 9.4.2 Rest of World Oral Proteins and Peptides Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Allergan
      • 10.1.1 Allergan Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.1.4 Oral Proteins and Peptides Product Introduction
      • 10.1.5 Allergan Recent Development
    • 10.2 AstraZeneca
      • 10.2.1 AstraZeneca Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.2.4 Oral Proteins and Peptides Product Introduction
      • 10.2.5 AstraZeneca Recent Development
    • 10.3 Biocon
      • 10.3.1 Biocon Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.3.4 Oral Proteins and Peptides Product Introduction
      • 10.3.5 Biocon Recent Development
    • 10.4 Generex Biotechnology
      • 10.4.1 Generex Biotechnology Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.4.4 Oral Proteins and Peptides Product Introduction
      • 10.4.5 Generex Biotechnology Recent Development
    • 10.5 Novo Nordisk
      • 10.5.1 Novo Nordisk Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.5.4 Oral Proteins and Peptides Product Introduction
      • 10.5.5 Novo Nordisk Recent Development
    • 10.6 Synergy Pharmaceuticals
      • 10.6.1 Synergy Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.6.4 Oral Proteins and Peptides Product Introduction
      • 10.6.5 Synergy Pharmaceuticals Recent Development
    • 10.7 Tarsa Therapeutics
      • 10.7.1 Tarsa Therapeutics Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.7.4 Oral Proteins and Peptides Product Introduction
      • 10.7.5 Tarsa Therapeutics Recent Development
    • 10.8 Sanofi
      • 10.8.1 Sanofi Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.8.4 Oral Proteins and Peptides Product Introduction
      • 10.8.5 Sanofi Recent Development
    • 10.9 Hoffmann-La Roche
      • 10.9.1 Hoffmann-La Roche Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.9.4 Oral Proteins and Peptides Product Introduction
      • 10.9.5 Hoffmann-La Roche Recent Development
    • 10.10 Synthetic Biologics
      • 10.10.1 Synthetic Biologics Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
      • 10.10.4 Oral Proteins and Peptides Product Introduction
      • 10.10.5 Synthetic Biologics Recent Development
    • 10.11 Hovione
    • 10.12 Novartis

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Oral Proteins and Peptides Sales Channels
      • 11.2.2 Oral Proteins and Peptides Distributors
    • 11.3 Oral Proteins and Peptides Customers

    12 Market Forecast

    • 12.1 Global Oral Proteins and Peptides Sales and Revenue Forecast 2019-2025
    • 12.2 Global Oral Proteins and Peptides Sales Forecast by Type
    • 12.3 Global Oral Proteins and Peptides Sales Forecast by Application
    • 12.4 Oral Proteins and Peptides Forecast by Regions
      • 12.4.1 Global Oral Proteins and Peptides Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Oral Proteins and Peptides Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.
      The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.
      The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.
      The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.
      In 2019, the market size of Oral Proteins and Peptides is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Proteins and Peptides.

      This report studies the global market size of Oral Proteins and Peptides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Oral Proteins and Peptides sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Allergan
      AstraZeneca
      Biocon
      Generex Biotechnology
      Novo Nordisk
      Synergy Pharmaceuticals
      Tarsa Therapeutics
      Sanofi
      Hoffmann-La Roche
      Synthetic Biologics
      Hovione
      Novartis

      Market Segment by Product Type
      Linaclotide
      Plecanatide
      Calcitonin
      Insulin
      Octreotide

      Market Segment by Application
      Gastric & Digestive Disorders
      Bone Diseases
      Diabetes
      Hormonal Disorders

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Oral Proteins and Peptides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Oral Proteins and Peptides manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Oral Proteins and Peptides are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now